跳至主要内容
临床试验/CTRI/2024/04/065596
CTRI/2024/04/065596尚未招募2/3 期

An Open Label Double Arm Comparative Clinical Study To Evaluate The Effect Of Lodhra, Tumbiphala Kalka And Lajjalu Kalka As Yonipichu.

Dr Shilpy Shukla1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年4月20日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Assessment based on subjective parameters Like Mass per vagina along with or without these symptoms as follows- Uterine incontinence, Backache, Dyspareunia, Fecal incontinence, Stress incontinence.

研究概览

简要总结

Pelvic organ prolapse is one of the clinical conditions seen in day today gynecological practice specifically amongst the parous women due to weakness of the structural support. These factors may be anatomical or clinical. The main presenting complaints include mass per vagina,urinary incontinence, overactive bladder, fecal incontinence.

Out of many Sthanika chikitsa yoni pichu advised in conditions like pelvic organ prolapse. Vaginal wall and adjacent tissues are extremely vascular and this facilitates absorption of drugs through vagina. anatomically backward position of vagina helps in self retaining of drugs for a longer duration. Hence, Yoni pichu has chosen for study .

It leaves a scope to find out a remedy which would offer cure of the disease, free from complications and economically better. Hence, yonipichu with lodra and tumbhi phala is choosen, which is economically better, with less complications and will help in strengthening the uterine and vaginal walls. It can also prevent first and second degree uterine prolapse to progress to third degree. The drug Lodhra is kashya and tikta rasa ,sheeta veerya and katu vipaka and Tumbiphala are Tikta Rasa ,katu Vipaka in nature and Mamsa vivardhana and lajjalu is tikta ,kashya rasa ,sheeta virya and it is yoniroganasat it helps for Yonidrudhikarana here.Thus there is need to know its efficacy in pelvic organ prolapse.

In first group tumbiphala and lodhra kalka as yonipichu will be used . In Second group lajjalu kalka as yonipichu will be used .

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
35.00 Year(s) 至 60.00 Year(s)(—)
性别
Female

入选标准

  • Female Patients between 35 and 60 years.
  • (both years inclusive) Uterine Prolapse First And Second Degree Mild To Moderate Rectocele Mild To Moderate Cystocele.

排除标准

  • Carcinoma of Cervix Any sexually transmitted disease Urethrocele Procedentia Any systemic illness which interferes with the course of treatment.

结局指标

主要结局

Assessment based on subjective parameters Like Mass per vagina along with or without these symptoms as follows- Uterine incontinence, Backache, Dyspareunia, Fecal incontinence, Stress incontinence.

时间窗: Efficacy of treatment will be assessed on the | subjective parameters at baseline and the end of | 30 days till 60 days.

次要结局

  • Assessment based on Objective parameters.(1 Prolapse assessed by POP quantification)

研究者

发起方
Dr Shilpy Shukla
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR SHILPY SHUKLA

Sri Kalabyraveswara Swamy Ayurvedic Medical College Hospital And Research Centre

研究点 (1)

Loading locations...

相似试验

A Clinical Trial To Study The Effect Of Lodhra,... | 临床试验